NASDAQ:AVXL
$9.14
(
0.440%
)
Friday, 2nd Jun 2023
Anavex Life Sciences Corp. Stock Price (Quote)
Range | Low Price | High Price | Comment |
---|---|---|---|
30 days | $8.02 | $9.73 | Friday, 2nd Jun 2023 AVXL stock ended at $9.14. This is 0.44% more than the trading day before Thursday, 1st Jun 2023. During the day the stock fluctuated 3.03% from a day low at $8.92 to a day high of $9.19. |
90 days | $7.44 | $10.37 | |
52 weeks | $7.36 | $15.24 |
Historical Anavex Life Sciences Corp. prices
Date | Open | High | Low | Close | Volume |
2023-06-02 | $9.17 | $9.19 | $8.92 | $9.14 | 810 965 |
2023-06-01 | $9.22 | $9.34 | $9.05 | $9.10 | 641 208 |
2023-05-31 | $9.18 | $9.45 | $9.00 | $9.24 | 647 791 |
2023-05-30 | $9.38 | $9.50 | $9.07 | $9.18 | 626 217 |
2023-05-26 | $9.24 | $9.36 | $8.95 | $9.32 | 954 334 |
2023-05-25 | $9.22 | $9.22 | $8.88 | $8.96 | 700 116 |
2023-05-24 | $9.17 | $9.27 | $9.06 | $9.21 | 745 267 |
2023-05-23 | $9.44 | $9.73 | $9.20 | $9.26 | 879 407 |
2023-05-22 | $9.45 | $9.59 | $9.35 | $9.50 | 665 276 |
2023-05-19 | $9.45 | $9.53 | $9.29 | $9.45 | 534 089 |
2023-05-18 | $9.50 | $9.50 | $9.04 | $9.29 | 734 717 |
2023-05-17 | $9.09 | $9.51 | $8.94 | $9.50 | 800 461 |
2023-05-16 | $9.36 | $9.38 | $8.87 | $9.01 | 934 319 |
2023-05-15 | $9.14 | $9.66 | $9.07 | $9.49 | 875 851 |
2023-05-12 | $9.26 | $9.30 | $8.88 | $9.10 | 523 049 |
2023-05-11 | $9.37 | $9.45 | $9.03 | $9.19 | 860 247 |
2023-05-10 | $9.32 | $9.63 | $9.04 | $9.36 | 1 240 485 |
2023-05-09 | $8.15 | $9.28 | $8.02 | $9.07 | 1 215 452 |
2023-05-08 | $8.42 | $8.45 | $8.20 | $8.41 | 852 097 |
2023-05-05 | $8.50 | $8.63 | $8.42 | $8.44 | 796 081 |
2023-05-04 | $8.32 | $8.49 | $8.12 | $8.40 | 788 778 |
2023-05-03 | $8.05 | $8.50 | $8.03 | $8.34 | 1 238 727 |
2023-05-02 | $8.28 | $8.39 | $7.96 | $8.00 | 989 446 |
2023-05-01 | $8.15 | $8.27 | $7.98 | $8.22 | 851 659 |
2023-04-28 | $8.20 | $8.23 | $8.05 | $8.14 | 672 697 |
2023-04-27 | $8.31 | $8.37 | $8.06 | $8.19 | 710 319 |
2023-04-26 | $7.76 | $8.29 | $7.66 | $8.24 | 1 204 854 |
2023-04-25 | $7.81 | $7.88 | $7.65 | $7.77 | 694 276 |
2023-04-24 | $8.01 | $8.03 | $7.68 | $7.85 | 606 684 |
2023-04-21 | $7.97 | $8.08 | $7.93 | $8.03 | 642 162 |
2023-04-20 | $8.15 | $8.15 | $7.93 | $7.97 | 857 448 |
2023-04-19 | $8.06 | $8.28 | $8.00 | $8.19 | 605 459 |
2023-04-18 | $8.16 | $8.16 | $7.99 | $8.12 | 703 452 |
2023-04-17 | $7.95 | $8.26 | $7.86 | $8.13 | 1 222 660 |
2023-04-14 | $8.02 | $8.04 | $7.65 | $7.88 | 866 103 |
2023-04-13 | $7.69 | $8.15 | $7.69 | $8.07 | 1 391 067 |
2023-04-12 | $7.75 | $7.88 | $7.59 | $7.66 | 696 334 |
2023-04-11 | $7.70 | $7.80 | $7.60 | $7.67 | 801 256 |
2023-04-10 | $7.78 | $7.78 | $7.44 | $7.70 | 1 250 531 |
2023-04-06 | $7.87 | $7.87 | $7.69 | $7.79 | 909 081 |
2023-04-05 | $7.97 | $8.10 | $7.80 | $7.87 | 838 191 |
2023-04-04 | $8.50 | $8.51 | $7.94 | $8.07 | 1 264 739 |
2023-04-03 | $8.53 | $8.62 | $8.36 | $8.51 | 835 817 |
2023-03-31 | $8.45 | $8.70 | $8.36 | $8.57 | 1 544 327 |
2023-03-30 | $8.86 | $8.98 | $8.25 | $8.32 | 2 169 873 |
2023-03-29 | $8.51 | $8.59 | $8.32 | $8.56 | 1 049 920 |
2023-03-28 | $8.50 | $8.61 | $8.27 | $8.32 | 785 004 |
2023-03-27 | $8.76 | $8.80 | $8.49 | $8.51 | 857 995 |
2023-03-24 | $8.60 | $8.79 | $8.42 | $8.72 | 1 081 776 |
2023-03-23 | $8.65 | $8.92 | $8.38 | $8.68 | 1 203 579 |
About Anavex Life Sciences Corp.
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinica... AVXL Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.